Hanne Fredly

424 total citations
12 papers, 357 citations indexed

About

Hanne Fredly is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Hanne Fredly has authored 12 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 4 papers in Genetics. Recurrent topics in Hanne Fredly's work include Acute Myeloid Leukemia Research (10 papers), Histone Deacetylase Inhibitors Research (6 papers) and Retinoids in leukemia and cellular processes (3 papers). Hanne Fredly is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Histone Deacetylase Inhibitors Research (6 papers) and Retinoids in leukemia and cellular processes (3 papers). Hanne Fredly collaborates with scholars based in Norway, France and Sweden. Hanne Fredly's co-authors include Øystein Bruserud, Bjørn Tore Gjertsen, Håkon Reikvam, Astrid Olsnes Kittang, Kimberley Joanne Hatfield, Elisabeth Ersvær, Galina Tsykunova, Knut Anders Mosevoll, Ina Nepstad and Ida Sofie Grønningsæter and has published in prestigious journals such as Molecular Cancer, Oncotarget and Cells.

In The Last Decade

Hanne Fredly

12 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanne Fredly Norway 11 254 213 64 52 41 12 357
Naïs Prade-Houdellier France 6 268 1.1× 147 0.7× 66 1.0× 36 0.7× 58 1.4× 6 389
Daniel Sasca Germany 8 307 1.2× 210 1.0× 73 1.1× 58 1.1× 40 1.0× 20 473
Céline Moison Canada 10 216 0.9× 105 0.5× 51 0.8× 23 0.4× 39 1.0× 17 295
Jiro Minami Japan 9 144 0.6× 103 0.5× 68 1.1× 40 0.8× 30 0.7× 21 266
Rebecca A. Bilardi Australia 8 219 0.9× 71 0.3× 68 1.1× 27 0.5× 22 0.5× 11 292
Daphné Dupéré-Richer United States 9 347 1.4× 77 0.4× 62 1.0× 42 0.8× 14 0.3× 18 409
Miriam Kull Germany 8 279 1.1× 130 0.6× 61 1.0× 19 0.4× 23 0.6× 16 335
Marcos J. Ruiz United States 3 135 0.5× 87 0.4× 124 1.9× 54 1.0× 45 1.1× 5 269
Lynn McCallum United Kingdom 9 208 0.8× 56 0.3× 35 0.5× 49 0.9× 33 0.8× 14 289
Alexey Khrenov United States 12 122 0.5× 192 0.9× 23 0.4× 23 0.4× 64 1.6× 20 329

Countries citing papers authored by Hanne Fredly

Since Specialization
Citations

This map shows the geographic impact of Hanne Fredly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Fredly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Fredly more than expected).

Fields of papers citing papers by Hanne Fredly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Fredly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Fredly. The network helps show where Hanne Fredly may publish in the future.

Co-authorship network of co-authors of Hanne Fredly

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Fredly. A scholar is included among the top collaborators of Hanne Fredly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Fredly. Hanne Fredly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Grønningsæter, Ida Sofie, Hanne Fredly, Bjørn Tore Gjertsen, Kimberley Joanne Hatfield, & Øystein Bruserud. (2019). Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy. Cells. 8(10). 1229–1229. 20 indexed citations
2.
3.
Haaland, Ingvild, Jill A. Opsahl, Frode S. Berven, et al.. (2014). Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Molecular Cancer. 13(1). 116–116. 25 indexed citations
4.
5.
Fredly, Hanne, Elisabeth Ersvær, Astrid Olsnes Kittang, et al.. (2013). The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia. Clinical Epigenetics. 5(1). 13–13. 46 indexed citations
6.
7.
Fredly, Hanne, Lars Bullinger, Véronique Mansat‐De Mas, et al.. (2013). CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia. Oncotarget. 4(9). 1438–1448. 17 indexed citations
8.
9.
Reikvam, Håkon, Kimberley Joanne Hatfield, Hanne Fredly, et al.. (2012). The angioregulatory cytokine network in human acute myeloid leukemia – from leukemogenesis via remission induction to stem cell transplantation. European Cytokine Network. 23(4). 140–153. 46 indexed citations
10.
11.
12.
Fredly, Hanne, Elisabeth Ersvær, Camilla Stapnes, Bjørn Tore Gjertsen, & Øystein Bruserud. (2009). The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials. Current Cancer Therapy Reviews. 5(4). 243–255. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naïs Prade-Houdellier Breakdown of academic impact, for papers by Daniel Sasca Breakdown of academic impact, for papers by Céline Moison Breakdown of academic impact, for papers by Jiro Minami Breakdown of academic impact, for papers by Rebecca A. Bilardi Breakdown of academic impact, for papers by Daphné Dupéré-Richer Breakdown of academic impact, for papers by Miriam Kull Breakdown of academic impact, for papers by Marcos J. Ruiz Breakdown of academic impact, for papers by Lynn McCallum Breakdown of academic impact, for papers by Alexey Khrenov
Rankless by CCL
2026